We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

QSR:NYSERestaurant Brands International Inc. Analysis

Data as of 2026-05-22 - not real-time

$76.25

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Restaurant Brands International posted Q1 earnings that beat consensus, with adjusted EPS of $0.86 and revenue growth of 7.3% YoY, reinforcing the company’s resilient top‑line momentum. Technical indicators show the 20‑day SMA comfortably above the 50‑day SMA, suggesting a short‑term bullish bias, while the MACD has turned bearish and volume is trending down, tempering enthusiasm. The stock is trading near its identified support around $74.8 and well below the recent resistance near $82, leaving limited upside in the near term. Momentum metrics such as an RSI in the mid‑40s indicate neither overbought nor oversold conditions, and a low beta points to modest price swings relative to the market. However, the 30‑day volatility approaching 27% signals notable price swings that could challenge tight‑range traders. The dividend yield of roughly 3.4% combined with an 80% payout ratio is sustainable given strong operating cash flow, though the balance sheet carries a high debt‑to‑equity ratio. A discounted cash flow model values the shares near $32, implying the current market price reflects a sizable premium. Analyst consensus remains “buy” with a mean target around $86, highlighting expectations for continued organic growth and upcoming buyback programs. Overall, the company blends solid earnings performance and cash generation with a valuation gap that warrants cautious optimism.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Earnings beat supports price stability
  • Bearish MACD and decreasing volume limit upside
  • Proximity to technical support level

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and operating margins
  • Attractive dividend yield with sustainable payout
  • Analyst consensus and upside potential to target price

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Diversified brand portfolio provides resilience
  • High debt level and valuation premium create headroom risk
  • Consistent cash flow generation supports dividend and buybacks

Key Metrics & Analysis

Financial Health

Revenue Growth7.30%
Profit Margin9.96%
P/E Ratio24.5
ROE28.14%
ROA6.44%
Debt/Equity296.41
P/B Ratio7.1
Op. Cash Flow$1.7B
Free Cash Flow$1.6B

Technical Analysis

TrendBullish
RSI45.1
Support$74.79
Resistance$81.96
MA 20$78.23
MA 50$76.80
MA 200$69.99
MACDBearish
VolumeDecreasing
Fear & Greed Index91.11

Valuation

Fair Value$32.06
Target Price$85.89
Upside/Downside12.64%
GradeOvervalued
TypeGrowth
Dividend Yield3.41%

Risk Assessment

Beta0.27
Volatility26.99%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.